AboutTeamPortfolioInsights

Biopharma company developing targeted cancer therapies for genetically-defined patient populations

Sectors
Healthcare
Life Sciences
First Invested
2014
Early
Company Status
IPO/Acquired
NASDAQ: LOXO
Acquired by Eli Lilly & Co.